InspireMD, Inc.
NSPR· Nasdaq
NSPRInspireMD, Inc.
Released Aug 5, 2024, after the close
10-Q filed Aug 5, 2024, 36 days after period end · 0001493152-24-030265
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $1.74M | $1.65M | $1.53M | $1.04M |
| Net Income | -$7.91M | -$5.08M | -$4.64M | -$3.51M |
| EPS Diluted | -$0.22 |
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
| -$0.24 |
| -$0.59 |
| -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
